Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00981435 · ClinicalTrials.gov registry record · Phase 4
Steroids After Laser Trabeculoplasty for Glaucoma
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 97
- Enrollment target
NCT00981435: Completed Phase 4 study, sponsored by Stanford University.
NCT00981435 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00981435, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 97 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).
Interventions
- DRUG Ketorolac
- DRUG Prednisolone 1%
- DRUG Artificial Tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2009-09 |
| Est. Completion | 2015-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00981435
The ClinicalTrials.gov registry entry for NCT00981435 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ketorolac is the first listed.
NCT00981435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00981435 about?
NCT00981435 is a clinical study titled "Steroids After Laser Trabeculoplasty for Glaucoma". The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).
What is the current status of trial NCT00981435?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 97 participants. The study started on 2009-09. Estimated completion is 2015-09.
What interventions are being tested in trial NCT00981435?
The interventions under investigation include: Ketorolac (DRUG), Prednisolone 1% (DRUG), Artificial Tears (DRUG).
Who is sponsoring clinical trial NCT00981435?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.